These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

316 related items for PubMed ID: 8120858

  • 1. Oral contraceptives for the prevention of osteoporosis.
    Corson SL.
    J Reprod Med; 1993 Dec; 38(12 Suppl):1015-20. PubMed ID: 8120858
    [Abstract] [Full Text] [Related]

  • 2. Rational use of oral contraceptives in the perimenopausal woman.
    Connell EB.
    J Reprod Med; 1993 Dec; 38(12 Suppl):1036-40. PubMed ID: 8120861
    [Abstract] [Full Text] [Related]

  • 3. Osteoporosis in anorexia nervosa: the influence of peak bone density, bone loss, oral contraceptive use, and exercise.
    Seeman E, Szmukler GI, Formica C, Tsalamandris C, Mestrovic R.
    J Bone Miner Res; 1992 Dec; 7(12):1467-74. PubMed ID: 1481732
    [Abstract] [Full Text] [Related]

  • 4. Changes in haemostatic variables induced by oral contraceptives containing 50 micrograms or 30 micrograms oestrogen: absence of dose-dependent effect on PAI-1 activity.
    Scarabin PY, Plu-Bureau G, Zitoun D, Bara L, Guize L, Samama MM.
    Thromb Haemost; 1995 Sep; 74(3):928-32. PubMed ID: 8571323
    [Abstract] [Full Text] [Related]

  • 5. Bone mineral density and history of oral contraceptive use.
    Fortney JA, Feldblum PJ, Talmage RV, Zhang J, Godwin SE.
    J Reprod Med; 1994 Feb; 39(2):105-9. PubMed ID: 8169923
    [Abstract] [Full Text] [Related]

  • 6. Risks of oral contraceptive use in women over 35.
    Stenchever MA.
    J Reprod Med; 1993 Dec; 38(12 Suppl):1030-5. PubMed ID: 8120860
    [Abstract] [Full Text] [Related]

  • 7. European Society of Contraception oral contraceptives survey update: birth control methods in "Europe of the 12".
    Serfaty D, Wildemeersch D, Verougstraete A, Creatsas G.
    Int J Fertil Menopausal Stud; 1995 Dec; 40 Suppl 2():73-9. PubMed ID: 8574253
    [Abstract] [Full Text] [Related]

  • 8. Bone-sparing properties of oral contraceptives.
    DeCherney A.
    Am J Obstet Gynecol; 1996 Jan; 174(1 Pt 1):15-20. PubMed ID: 8571999
    [Abstract] [Full Text] [Related]

  • 9. The misunderstood pill: thirty years of testing and development have reduced pill's major, minor side effects.
    United States. Centers for Disease Control CDC. Advisory Committee on Immunization Practices.
    Netw Res Triangle Park N C; 1986 Jan; 7(4):1-5. PubMed ID: 12341093
    [Abstract] [Full Text] [Related]

  • 10. Oral contraceptive use may protect against low bone mass. Henry Ford Hospital Osteoporosis Cooperative Research Group.
    Kleerekoper M, Brienza RS, Schultz LR, Johnson CC.
    Arch Intern Med; 1991 Oct; 151(10):1971-6. PubMed ID: 1929685
    [Abstract] [Full Text] [Related]

  • 11. The risk of serious illness among oral contraceptive users: evidence from the RCGP's oral contraceptive study.
    Hannaford PC, Kay CR.
    Br J Gen Pract; 1998 Oct; 48(435):1657-62. PubMed ID: 10071398
    [Abstract] [Full Text] [Related]

  • 12. Age at first oral contraceptive use as a major determinant of vertebral bone mass in female endurance athletes.
    Hartard M, Kleinmond C, Kirchbichler A, Jeschke D, Wiseman M, Weissenbacher ER, Felsenberg D, Erben RG.
    Bone; 2004 Oct; 35(4):836-41. PubMed ID: 15454090
    [Abstract] [Full Text] [Related]

  • 13. Noncontraceptive health benefits and risks of steroidal contraception.
    Pasquale SA.
    Int J Fertil; 1989 Oct; 34 Suppl():85-7. PubMed ID: 2576266
    [Abstract] [Full Text] [Related]

  • 14. Noncontraceptive benefits of oral contraceptive use: an evidence-based approach.
    Williams JK.
    Int J Fertil Womens Med; 2000 Oct; 45(3):241-7. PubMed ID: 10929688
    [Abstract] [Full Text] [Related]

  • 15. Oral contraceptives.
    Maclennan AH.
    Curr Ther (Seaforth); 1987 Dec; 28(12):113-22. PubMed ID: 12317413
    [Abstract] [Full Text] [Related]

  • 16. Longitudinal evaluation of perimenopausal bone loss: effects of different low dose oral contraceptive preparations on bone mineral density.
    Gambacciani M, Cappagli B, Lazzarini V, Ciaponi M, Fruzzetti F, Genazzani AR.
    Maturitas; 2006 May 20; 54(2):176-80. PubMed ID: 16332417
    [Abstract] [Full Text] [Related]

  • 17. Physiologic and pharmacologic effects of estrogen and progestins on bone.
    DeCherney A.
    J Reprod Med; 1993 Dec 20; 38(12 Suppl):1007-14. PubMed ID: 8120857
    [Abstract] [Full Text] [Related]

  • 18. 30 years of change: the current perspective on cardiovascular risks and oral contraceptives.
    Contracept Rep; 1995 May 20; 6(2):4-9, 14. PubMed ID: 12319497
    [Abstract] [Full Text] [Related]

  • 19. Researchers can now investigate long-term effects of OCs on cancer.
    Rubin GL, Peterson HB.
    Contracept Technol Update; 1985 Jan 20; 6(1):7-12. PubMed ID: 12279918
    [Abstract] [Full Text] [Related]

  • 20. Consider prescribing OCs for perimenopause use.
    Contracept Technol Update; 2000 Mar 20; 21(3):31-3. PubMed ID: 12349548
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.